v3.26.3
Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Net earned premium $ 128.3 $ 99.7 $ 345.9 $ 281.0
Commission income, net 15.6 10.5 44.0 39.6
Service and fee income 4.1 3.1 11.0 8.8
Net investment income 8.0 7.3 21.3 18.8
Total revenue 156.0 120.6 422.2 348.2
Expenses:        
Losses and loss adjustment expenses 72.7 47.5 180.0 184.4
Insurance related expenses 39.3 32.9 112.9 95.9
Technology and development expenses 11.0 8.0 30.5 24.2
Sales and marketing expenses 5.9 8.0 18.5 26.1
General and administrative expenses 17.0 16.5 51.4 50.4
Impairment and restructuring charges 0.0 3.8 0.0 5.0
Gain on sale of business 0.0 (95.0) 0.0 (95.0)
Interest and other expense, net 1.2 0.8 1.8 0.7
Total expenses 147.1 22.5 395.1 291.7
Income before income taxes 8.9 98.1 27.1 56.5
Income tax expense (benefit) 0.1 0.0 1.1 (0.1)
Net income 8.8 98.1 26.0 56.6
Net income attributable to noncontrolling interests, net of tax 0.0 0.0 0.0 4.9
Net income attributable to Hippo 8.8 98.1 26.0 51.7
Other comprehensive (loss) income:        
Change in net unrealized (loss) gain on investments, net of tax (12.5) 1.3 (16.3) 4.1
Comprehensive (loss) income attributable to Hippo $ (3.7) $ 99.4 $ 9.7 $ 55.8
Per share data:        
Net income per share attributable to Hippo - basic (in dollars per share) $ 0.33 $ 3.90 $ 0.99 $ 2.04
Net income per share attributable to Hippo - diluted (in dollars per share) $ 0.33 $ 3.77 $ 0.98 $ 1.97
Weighted-average shares used in computing net loss per share attributable to Hippo - basic (in shares) 26,499,520 25,183,389 26,183,300 25,362,467
Weighted-average shares used in computing net loss per share attributable to Hippo - diluted (in shares) 27,030,298 26,025,069 26,628,602 26,186,034